MedTrace Logo

Observational Study on the Efficacy and Tolerance of EYEBRID Lenses

NCT05036954 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-09-08

No results posted yet for this study

Summary

Technical advances in lenses are continuous and materials are improved. We provide a prospective longitudinal observational study evaluating the efficacy and safety of new EyeBrid Excel hybrid lenses (LCS) in the treatment of severe ametropia and for patients with corneal irregularities.

This study should include 60 patients for a period of three months. The aim of this work is to assess the improvement in the best corrected visual acuity and the good tolerance of this lens.

Conditions

  • Contact Lens Complication

Interventions

DEVICE

EyeBrid Excel hybrid lenses

new lenses

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2021-11-30
Completion
2022-07-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05036954 on ClinicalTrials.gov